Spatial Remodeling of the Sphingolipid Rheostat in Colorectal Carcinogenesis.

Colorectal carcinogenesis involves coordinated reorganization of epithelial architecture, metabolism, and microenvironmental interactions. Among lipid signaling pathways, the sphingolipid rheostat has traditionally been described as a balance between ceramides and sphingosine-1-phosphate (S1P), with opposite effects on cell death and survival. However, current evidence suggests that this model is too simplified for colorectal cancer. Here, we discuss the sphingolipid rheostat as a spatially organized and stage-dependent signaling network shaped by enzymatic control, lipid transport, extracellular carrier association, and receptor context. During adenoma formation, ceramide-related metabolic programs may support progenitor cell function, while luminal ceramide generation by alkaline sphingomyelinase provides a surface-associated checkpoint linked to epithelial turnover. In carcinomas, coordinated rewiring of multiple regulatory nodes, including increased S1P synthesis, reduced degradation, altered export, and diversion of ceramide into complex sphingolipids, appears to favor persistent pro-survival signaling. These changes are associated with apoptosis resistance, angiogenesis, invasion, and immune modulation. We further emphasize that sphingolipid signaling depends on exposure biology, including cellular source, transporter usage, and carrier distribution in the circulation. This framework may help explain why blood-based sphingolipid measurements do not always reflect tumor-local sphingolipid organization. A compartment-aware view of sphingolipid biology may therefore improve interpretation of lipid biomarkers and identify stage-specific therapeutic vulnerabilities.